Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Validation status of cognitive digital assessments by the FDA BEST framework and context of use in preclinical AD studies: A systematic review 2025-12-01
  2. Alzheimer's disease diagnostic accuracy by fluid and neuroimaging ATN framework 2023-07-12
  3. The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology 2021-05-21

Studies

3 studies carry this tag.

Date range

2021 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 2
  • CNS neuroscience & therapeutics 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Validation status of cognitive digital assessments by the FDA BEST framework and context of use in preclinical AD studies: A systematic review

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-12-01 Cognitive tests and assessment

    Digital cognitive assessments have rapidly expanded in Alzheimer's disease (AD) research, offering a sensitive, scalable, and cost-effective alternative to traditional neuropsychological tests.

  2. Alzheimer's disease diagnostic accuracy by fluid and neuroimaging ATN framework

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. CNS neuroscience & therapeutics 2023-07-12 Biomarkers

    Our findings suggest that plasma, CSF, and neuroimaging biomarkers differ considerably within the ATN framework; the most accurate target biomarkers for diagnosing AD were the CSF-A, neuroimaging-T, and neuroimaging-N within each ATN modality.

  3. The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2021-05-21 Brain scans and imaging

    Patients with early-onset Alzheimer's disease (EOAD) are commonly excluded from large-scale observational and therapeutic studies due to their young age, atypical presentation, or absence of pathogenic mutations.

All topic tags with their study counts